Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05919992

The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)

The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation

Sponsor: Eleonora Seelig

Interventions Hydrocortisone 19.9mg s.c., pulsatile with a flow rate of 10μl/s Metyrapone 250 mg Oral Tablets Placebo (0,9% NaCl solution) Placebo 250 mg Tablets

Updated 3 times since 2023 Last updated: Aug 13, 2024 Started: May 15, 2023 Primary completion: Jul 25, 2024 Completion: Jul 25, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05919992, this EARLY_PHASE1 trial focuses on Glucocorticoid Effect and remains completed. Sponsored by Eleonora Seelig, it has been updated 3 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Jul 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1
Jul 2023 — Jul 2024 [monthly]

Recruiting EARLY_PHASE1

First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eleonora Seelig

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland